Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial
Description
CONCLUSION: Our study showed that the RCP efficacy is non-inferior and its safety profile is comparable to the BBIBP.
